Effectiveness of the “Managing fatigue individually” self-management program program in cancer and long-COVID patients - online versus presence

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035053

Enrollment

156

Registered

2024-12-30

Start date

2024-09-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with long COVID or oncological diseases

Interventions

Group 1: Patients are assigned to one of the two groups depending on their underlying disease: Long COVID vs. oncological diseases Group 2: Depending on the patients preference, technical requirements

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Fatigue symptoms with long COVID or oncological disease

Exclusion criteria

Exclusion criteria: Severe physical and / or cognitive impairment, language barrier

Design outcomes

Primary

Measure	Time frame
1) Reduction of fatigue symptoms in participants of the “Manage Fatigue Individually” self-management program compared to the waiting list group. 2) Differences in fatigue symptom improvement between cancer and long-COVID patients within the program. 3) Comparison of the effectiveness of the program between online and face-to-face participants. 4) Questions/questionnaires: - Disease-related questions, sociodemographic characteristics - Fatigue Assessment Scale (FAS), HADS; PHQ-4; HSI-MV; EORTC QLQ C30; PEM, PSQI (sleep quality) - Sit-to-stand test	—

Measure

Time frame

1) Reduction of fatigue symptoms in participants of the “Manage Fatigue Individually” self-management program compared to the waiting list group. 2) Differences in fatigue symptom improvement between cancer and long-COVID patients within the program. 3) Comparison of the effectiveness of the program between online and face-to-face participants. 4) Questions/questionnaires: - Disease-related questions, sociodemographic characteristics - Fatigue Assessment Scale (FAS), HADS; PHQ-4; HSI-MV; EORTC QLQ C30; PEM, PSQI (sleep quality) - Sit-to-stand test

—

Secondary

Measure	Time frame
1) Improvement in the quality of life of participants in the self-management program compared to the waiting list group. 2) Differences in quality of life improvement between cancer and long-term COVID patients within the program. 3) Comparison of the long-term effects of the program between online and face-to-face participants. Further influencing variables: Disease, psychosocial and sociodemographic variables	—

Measure

Time frame

1) Improvement in the quality of life of participants in the self-management program compared to the waiting list group. 2) Differences in quality of life improvement between cancer and long-term COVID patients within the program. 3) Comparison of the long-term effects of the program between online and face-to-face participants. Further influencing variables: Disease, psychosocial and sociodemographic variables

—

Countries

Germany

Contacts

Public ContactAnke Steinmetz

Universitätsmedizin Greifswald, Physikalische und Rehabilitative Medizin

anke.steinmetz@med.uni-greifswald.de03834854163

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026